R&D

What is the future of healing?

What is the future of healing?

Written by on July 23, 2014 in Research & Development with 0 Comments

What is the future of the healthcare industry? What will the healing of tomorrow look like? CNN’s Top 10 may have the answer! CNN have taken a closer look at the innovations of today that could lead to the cures of tomorrow. Below is a brief run down of CNN’s top 10. Find out more […]

Continue Reading

Clinical Trials: Cooperation and Big Data Sharing is the Way Forward

Clinical Trials: Cooperation and Big Data Sharing is the Way Forward

Big Pharma companies are hiring Big Data analytics firms to protect privacy of shared data Important initiatives are emerging for big pharma companies to render their trials results accessible to other companies and to researchers. The spread of this tendency would make drug development more efficient and save the industry billions. Indeed, if researchers could […]

Continue Reading

Drug Discovery

Download the Interview: Boosting the Innovation Machine in Pharma R&D

Download the Interview: Boosting the Innovation Machine in Pharma R&D

An interview with François-Henri Boissel, CEO of Novadiscovery, on Pharma R&D biggest challenges and the need for a new innovation paradigm. Download a copy here In this interview, we asked François-Henri Boissel, CEO of Novadiscovery, for his view on the traditional drug R&D process, and how it could be modified to better predict real world performance and adverse events. […]

Continue Reading

Download Ebook: 15 promising Asian biotechs to watch

Download Ebook: 15 promising Asian biotechs to watch

Written by on July 9, 2014 in Drug Discovery, Featured on app, Whitepapers with 0 Comments

As Asia’s stake in the global pharmaceutical market continues to grow due to both the vast amount of investment we have seen in R&D over the past few years and the exciting pipelines that up and coming Asian biotech companies have been developing, now more than ever Asia is a market to watch. Click here […]

Continue Reading

Clinical Trials

Clinical Trial Management System Market, Trends and Forecasts

Clinical Trial Management System Market, Trends and Forecasts

Written by on July 24, 2014 in Clinical Trials with 0 Comments

A new report has stated that the global Clinical Trial Management System (CTMS) market “is expected to grow at a CAGR (compound annual growth rate) of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019″, compared with USD 844.0 million in 2013. CTMS is a software system which […]

Continue Reading

Download Ebook: Top Ten Key Issues Regarding EU Clinical Trials Regulation

Download Ebook: Top Ten Key Issues Regarding EU Clinical Trials Regulation

Written by on July 22, 2014 in Clinical Trials with 0 Comments

The EU Clinical Trials regulation was adopted on 16th April 2014 and comes into force in 2016. It replaces a convoluted Clinical Trials Directive and aims to streamline clinical trial applications across the EU. Although it is a positive move forward, it brings with it, its own issues, from protecting commercially sensitive information to setting […]

Continue Reading

Manufacturing

Global cell culture market to grow at 10.27% CAGR by 2018

Global cell culture market to grow at 10.27% CAGR by 2018

Written by on July 23, 2014 in Cell Culture, Manufacturing with 0 Comments

The global cell culture market will grow at a CAGR of 10.27 percent over the period of 2013-2018, predict analysts in a recently released report. The major driver behind this growth is the increased demand for biopharmaceuticals, particularly with growth in the global biosimilar and follow-on biologic market. Biopharmaceuticals can offer improved efficacy over many traditional […]

Continue Reading

Download: The Evolving Landscape of Real World Evidence Development

Download: The Evolving Landscape of Real World Evidence Development

Written by on July 22, 2014 in Featured on app, Manufacturing, Reports with 0 Comments

  Marcus D Wilson, Pharm.D. gave an in depth presentation at last year’s Evidence USA event in Boston on “The Evolving Landscape of Real World Evidence Development: Understanding Value.”  In his presentation, he drives home the point that of all the relationships in healthcare, this one is the most important. Key topics discussed in the […]

Continue Reading

Regulation & Compliance

Download: Effective development and implementation of a compliance programme

Download: Effective development and implementation of a compliance programme

Written by on July 22, 2014 in Featured on app, Regulation and Compliance, Reports with 0 Comments

Kristine Aachmann Bethe, Corporate Counsel, Business Ethics Compliance Office, Novo Nordisk A/S gave a presentation at Pharma Compliance 2013 on the effective development and implementation of a compliance programme. Her presentation began by highlighting why compliance is so important to Novo Nordisk, explaining that now, as part of big pharma, there are increased demands and expectations to […]

Continue Reading

Global Biosimilar/Follow-on Biologic market expected to reach $36bn by 2020

Global Biosimilar/Follow-on Biologic market expected to reach $36bn by 2020

Written by on July 21, 2014 in Biosimilars, Regulation and Compliance with 0 Comments

We’re now mid-way through the long anticipated decade of spectacular ‘patent cliffs’. With some of the pharmaceutical industry’s biggest blockbuster biologics coming off patent, it seems that the market for biosimilar and follow-on biologic products is due to explode. A recently released report suggests that the global market will reach $36 billion by the year […]

Continue Reading

Pricing & Market Access

AstraZeneca’s Ajay Gautam on Innovative R&D for Emerging Markets

AstraZeneca’s Ajay Gautam on Innovative R&D for Emerging Markets

We were glad to have Ajay Gautam, Executive Director and Head of Emerging Markets R&D at AstraZeneca, present at last year’s BioPharma Mexico. You can now download his slides from the event, where he addressed innovative R&D models for emerging markets under the main heading “How to grow the Mexican pharma industry”. View the presentation […]

Continue Reading

Pharma M&A on Steroids: Pfizer Breakdown

Pharma M&A on Steroids: Pfizer Breakdown

Pharma M&A activity has seen such an uptake in recent weeks and the industry is alive with developments and momentum. Andrew Badrot, a speaker at the Pharma M&A Briefing on 10th June has kindly analysed the role that Pfizer has played in the market in this guest blog. The industry has been on a roller […]

Continue Reading

Engagement & Marketing

Who is pushing the boundaries in pharma engagement?

Written by on July 22, 2014 in Engagement & Communications, Featured Videos with 0 Comments

It is one thing to discuss and debate the benefits of evolving Pharma businesses with multichannel engagement strategy, but who is actually doing it? This question was posed to two of our attendees at DigiPharm 2013, Tim Ringrose, CEO, Networks in Health and Ken Phillips, Client Director, eGain. Take a look at the video for […]

Continue Reading

Download: The future of Pharma

Download: The future of Pharma

Written by on July 22, 2014 in Engagement & Communications, Featured on app, Reports with 0 Comments

At DigiPharm 2013, we were joined by Professor Brian D. Smith, author of “The Future of Pharma” who gave an in-depth presentation on how pharma has evolved and where it is heading. What science can we use to make sense of the changes in the pharma sector? What does evolutionary economics predict for the future […]

Continue Reading

Partnering & Investment

Announcing The Marriage of Big Pharma and Big Data

Announcing The Marriage of Big Pharma and Big Data

Novartis teams up with Google to develop “smart” lens This week a partnership between Goggle and Novartis has been announced, for the development of a “smart” contact lens to help diabetics track their blood sugar levels. This is the first big partnership made public between big pharma and big data to work together to revolutionise […]

Continue Reading

Today and tomorrow’s world – not-for-profits join with industry to develop drugs

Today and tomorrow’s world – not-for-profits join with industry to develop drugs

Written by on July 17, 2014 in Partnering & Investment with 0 Comments

I’ve had several conversations with pharmaceutical industry experts in the last few days. There seems to be increasing interest from sponsors marrying up with research charities. I thought that I would share some examples with you. Cancer Research UK developed Clinical Development Partnerships (CDP) meaning that de-prioritised agents can be given a second chance. The […]

Continue Reading

Other Recent Posts

Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system

July 24, 2014: Royal Philips today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative ultra mobile ultrasound system, VISIQ, in the U.S. VISIQ is the first Philips ultrasound system to combine the benefits of greater mobility, performance and simplicity into a single miniaturized solution, helping clinicians increase access to […]

Continue Reading

Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology

July 24, 2014 : Cypher Genomics, Inc., the genome informatics company, announced today the appointment of Adam Simpson as president and chief operating officer (COO). Cypher Genomics provides rapid and comprehensive annotation and interpretation of individual human genomes for biomarker discovery and clinical reporting. “Cypher’s technology has the potential to play a transformative role to improve healthcare by enhancing diagnostic […]

Continue Reading

WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division

July 24, 2014: WIRB-Copernicus Group® (“WCG”)™, the world’s largest provider of regulatory and ethical review services for clinical research, announced today that it has acquired Alliance Biosciences. Formerly a division ofRichmond, VA-based Alliance Engineering, Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States. With this addition, WCG’s biosafety division – WCG Biosafety™ […]

Continue Reading

TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform

July 24, 2014: Cognizant  today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials. TransCelerate BioPharma Inc. is dedicated to making the research and development process […]

Continue Reading

Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea

July 24, 2014: Bayer HealthCare today announced positive results from a Phase III trial that evaluated a 15% foam formulation of its compound azelaic acid (AzA) for the topical treatment of inflammatory papules and pustules of rosacea. An AzA foam formulation is a potential treatment option to complement the currently available AzA gel formulation. Papulopustular […]

Continue Reading

Top
Geolocation